ChemicalBook > Product Catalog >API >Nervous system drugs >Antidepressants, Antimanics drugs >Sertraline


Sertraline Suppliers list
Company Name: Henan Tianfu Chemical Co.,Ltd.
Tel: +86-0371-55170693 +86-19937530512
Products Intro: Product Name:Sertraline HCL API
Purity:99% Package:25KG;5KG;1KG
Company Name: career henan chemical co
Tel: +86-0371-86658258
Products Intro: Product Name:Sertraline
CAS: 79617-96-2
Purity:98% Package:1KG;1USD
Tel: +86 18953170293
Products Intro: Product Name:Sertraline
Purity:0.99 Package:5KG;1KG
Company Name: Chongqing Chemdad Co., Ltd
Tel: 86-13650506873
Products Intro: Product Name:Sertraline
Purity:0.98 Package:1kg,2kg,5kg,10kg,25kg
Company Name: Alchem Pharmtech,Inc.
Tel: 8485655694
Products Intro: Product Name:(1S,4S)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
Purity:97+% Package:1g;10g;100g;;1kg Remarks:Z-61930

Sertraline manufacturers

  • Sertraline
  • $10.00 / 5g
  • 2023-03-11
  • CAS:79617-96-2
  • Min. Order: 10g
  • Purity: 99%
  • Supply Ability: 2546245
  • Sertraline
  • $55.00 / 1kg
  • 2023-02-13
  • CAS:79617-96-2
  • Min. Order: 1kg
  • Purity: 99%
  • Supply Ability: 70MT
  • Sertraline USP/EP/BP
  • $1.10 / 1g
  • 2021-07-27
  • CAS:79617-96-2
  • Min. Order: 1g
  • Purity: 99.9%
  • Supply Ability: 100 Tons min
Sertraline Basic information
Product Name:Sertraline
Synonyms:Sertraline HCL API;Sertraline Base;1-NaphthalenaMine,4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-Methyl-, (1S,4S)-;(1s-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-n-methyl-1-naphthalenamin;1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-n-methyl-1-naphthalenamin(1s-cis;cp51974;(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydro-1-naphthalenamine;(1s-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-naphthalenamine
Product Categories:API;Amines;(intermediate of sertraline hcl);Sertraline
Mol File:79617-96-2.mol
Sertraline Structure
Sertraline Chemical Properties
Boiling point 416.3±45.0 °C(Predicted)
density 1.25±0.1 g/cm3(Predicted)
pkapKa 9.48±0.04(H2O I > 0)(Approximate)
Water Solubility <0.1g/L(room temperature)
CAS DataBase Reference79617-96-2(CAS DataBase Reference)
NIST Chemistry ReferenceSertraline(79617-96-2)
EPA Substance Registry SystemSertraline (79617-96-2)
Safety Information
Hazard Codes Xi
Risk Statements 36/37/38
Safety Statements 26-36
Hazardous Substances Data79617-96-2(Hazardous Substances Data)
MSDS Information
Sertraline Usage And Synthesis
UsesAntidepressant;5-HT uptake inhibitor
Usescis-Sertraline is an isomer of Sertraline. Sertraline is a selective serotonin reuptake inhibitor. It is used as an antidepressant.
DefinitionChEBI: A member of the class of tetralins that is tetralin which is substituted at positions 1 and 4 by a methylamino and a 3,4-dichlorophenyl group, respectively (the S,S diastereoisomer). A selective serotonin-reuptake inhibito (SSRI), it is administered orally as the hydrochloride salt as an antidepressant for the treatment of depression, obsessive-compulsive disorder, panic disorder and post-traumatic stress disorder.
Brand nameZoloft (Pfizer).
Therapeutic FunctionAntidepressant
Biological FunctionsSertraline (Zoloft) has an elimination half-life of 25 hours and can be administered once a day, usually in the morning to avoid insomnia. Sertraline undergoes extensive hepatic metabolism, and doses must be reduced in patients with liver disease. Sertraline may produce more gastrointestinal side effects, such as nausea and diarrhea, than does fluoxetine and is generally thought to be less activating than fluoxetine. It is highly bound to serum proteins (98%) and may alter plasma protein binding of other medications.A 14-day washout period is recommended before starting a MAOI. Sertraline is a weak inhibitor of cytochrome P450 2D6. Intensive therapeutic drug monitoring is indicated when combining sertraline with drugs metabolized by this route that have a narrow therapeutic index, such as the TCAs and the type 1C antiarrhythmics propafenone, encainide, and flecainide.
General DescriptionInspection of sertraline (Zoloft) (1S,4S) reveals the pharmacophorefor SERT inhibition. The Cl substituents alsopredict tropism for a 5-HT system. The depicted stereochemistryis important for activity.
Mechanism of actionSertraline is a potent and selective inhibitor of the neuronal reuptake 5-HT transporter. In vitro binding studies suggest that sertraline has a substantially higher selectivity for inhibiting 5-HT reuptake than other SSRIs or TCAs, including clomipramine. It has only weak effects on neuronal uptake of NE and dopamine. Its mechanism of action is common to the SSRIs. Sertraline is very selective, lacking affinity for other neuroreceptors at therapeutic concentrations.
PharmacokineticsSertraline appears to be slowly but well absorbed from the GI tract following oral administration. The oral bioavailability of sertraline in humans ranges from 20 to 36%, suggesting extensive first-pass metabolism to its N-desmethylated metabolite. Food enhances its oral absorption decreasing the time to achieve peak plasma concentrations from approximately 8 to 6 hours. Following multiple dosing, steady-state plasma sertraline concentrations are proportional and linearly related to dose (half-life: single dose, 24 hours; multiple dose, 24 hours). N-desmethylsertraline, sertraline's principal metabolite, exhibits dose-dependent pharmacokinetics. Sertraline and N-desmethylsertraline are distributed into breast milk. Although in elderly patients the elimination half-life is increased to approximately 36 hours, this effect does not appear to be clinically important and does not warrant dosing alterations. Sertraline is primarily metabolized by CYP3A4 N-demethylation in the intestine and liver to its principal metabolite N-desmethylsertraline and several other metabolites. N-desmethylsertraline is approximately 5- to 10 times less potent as an inhibitor of 5-HT reuptake than sertraline. Sertraline and N-desmethylsertraline undergo further metabolism via oxidative deamination and ring hydroxylation and glucuronide conjugation. N-desmethylsertraline has an elimination half-life approximately 2.5 times that of sertraline. Following oral administration, sertraline and its conjugated metabolites are excreted in both urine and feces, and unmetabolized sertraline accounts for less than 5% of oral dose. Plasma clearance of sertraline was approximately 40% lower in geriatric patients. The elimination half-life of sertraline in patients with hepatic disease was prolonged to a mean of 52 hours, compared with 22 hours in individuals without hepatic disease.
Clinical UseSSRI:
Post-traumatic stress disorder
Obsessive compulsive disorder
Drug interactionsSertraline is not a potent inhibitor of CYP3A4, and because CYP2D6 metabolism is a minor pathway for sertraline, drug–drug interactions with these isoforms is unlikely to be of clinical importance. Sertraline is metabolized by more than one CYP isoform in parallel; therefore, drug interactions or genetic polymorphisms are unlikely to cause clinically significant drug interaction via CYP isoform inhibition. Caution is advised, however, when coadministering sertraline with potential object drugs, especially those with narrow therapeutic indices in elderly patients. For example, sertraline has been shown to reduce the clearance of desipramine and imipramine as a result of CYP2D6 inhibition.
Because sertraline is highly protein bound, patients receiving it concurrently with any highly protein-bound drug should be observed for potential adverse effects associated with combined therapy.
MetabolismSertraline undergoes extensive first-pass metabolism in the liver. The main pathway is demethylation to inactive N-desmethylsertraline, a process that appears to involve multiple cytochrome P450 isoenzymes; further metabolism and glucuronide conjugation occurs. Sertraline is excreted in about equal amounts in the urine and faeces, mainly as metabolites.
Tag:Sertraline(79617-96-2) Related Product Information
(1S,4S)-4-(3,4-dichlorophenyl)-N-(trideuteriomethyl)-1,2,3,4-tetrahydronaphthalen-1-amine:hydrochloride Rac-trans-Sertraline SERTRALINE MANDELATE,SERTRALINE HYDROCHLORIDE,SERTRALINE HCL FORM II,SERTRALINE HCL FORM I Paroxetine Amitriptyline (1S,4R)-N-Desmethyl Sertraline Hydrochloride 4-(3,4-dichlorophenyl)-1-tetralone (intermediate of sertraline) SERTRALINE HCL FORM I & III DESMETHYL SERTRALINE HCL,(1S,4S)-N-Desmethyl Sertraline Hydrochloride rac-trans-N-Desmethyl Sertraline Hydrochloride SERTRALINE HYDROCHLORIDE MM(CRM STANDARD) RAC CIS N-DESMETHYL SERTRALINE-D3 RAC-SERTRALINE-D3 Recemic Sertraline Hydrochloride SERTRALINE-D3 SERTRALINE RACEMATE HCl,Sertraline basis,Sertraline hydrechloride SERTRALINE-D3 HCL (1S,4R) Sertraline Hydrochloride